Femasys is trading at $3.22, down -6.12% during the September 1, 2026 session as U.S. stocks weaken amid renewed U.S.-Iran tensions, higher oil prices, and rising Treasury yields.
- The Nasdaq fell 1.2% shortly after the open, while higher yields pressured high-valuation growth stocks.
- No new Femasys announcement appears on its investor-relations calendar after the August 26 UNC Health partnership.